Anti-Lp-PLA2 antibody [11207] (STJ400248)
SPECIFICATIONS
ClonalityMonoclonal
HostMouse
ConjugationUnconjugated
IsotypeIgG1
ImmunogenNot determined
General Information
| Short Description | Mouse monoclonal anti-Lp-PLA2 for use in FIA in Human samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | FIA |
| Host | Mouse |
| Reactivity | Human |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Monoclonal |
| Clone ID | 11207 |
| Isotype | IgG1 |
| Conjugation | Unconjugated |
| Concentration | 5.0 mg/ml (+/-10 %) |
| Formulation | 50 mM citrate, pH 6.0, 0.9 % NaCI, 0.095 % NaN3 as a preservative |
| Storage Instruction | Store at 2–8 °C, and do not freeze. |
Target Information
| Immunogen | Not determined |
| Specificity | Antibody recognizes human lipoprotein-associated phospholipase A2. Not determined |
Additional Info
| Background | Lipoprotein-associated phospholipase A2 (Lp-PLA2) also known as platelet-activating factor acetylhydrolase (PAF-AH) is an enzyme involved in atherosclerosis related vascular inflammation. Increased Lp-PLA2 mass and activity are prognostic biomarkers for cardiovascular disease (CVD) including coronary heart disease and ishcemic stroke. |
Information sourced from Uniprot.org